Correction: CytRx FDA Letter

LOS ANGELES (AP) ¿ In a Sept. 8 story about CytRx Corp.'s response to a Food and Drug Administration letter, The Associated Press reported erroneously that CytRx said the FDA requested more information on a trial of arimoclomol. The letter provided a framework for a revised protocol for human testing to resume, but did not include a request for more information.

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

More from Food & Drink

From Finance to Fast Food: Women are Dominating this Week

From Finance to Fast Food: Women are Dominating this Week

The Demise of the Great American Supermarket (Watch!)

The Demise of the Great American Supermarket (Watch!)

The Great American Supermarket No Longer Reigns Supreme

The Great American Supermarket No Longer Reigns Supreme

Kohl's May Blame Winter Weather for First-Quarter Earnings Slip

Kohl's May Blame Winter Weather for First-Quarter Earnings Slip

Watch McDonald's Workers Storm HQ to Protest Fast-Food Giant's Pay

Watch McDonald's Workers Storm HQ to Protest Fast-Food Giant's Pay